Literature DB >> 24554430

RAGE signaling deficiency in rhabdomyosarcoma cells causes upregulation of PAX7 and uncontrolled proliferation.

Francesca Riuzzi1, Guglielmo Sorci, Roberta Sagheddu, Angelo Sidoni, Rita Alaggio, Vito Ninfo, Rosario Donato.   

Abstract

Embryonal rhabdomyosarcomas (ERMSs) show elevated levels of PAX7, a transcription factor that marks quiescent adult muscle stem (satellite) cells and is important for proliferation and survival of activated satellite cells and whose timely repression is required for myogenic differentiation. However, the mechanism of PAX7 accumulation in ERMSs and whether high PAX7 causes uncontrolled proliferation in ERMS remains to be elucidated. The receptor for advanced glycation end-products (RAGE, encoded by AGER) transduces a myogenic and anti-proliferative signal in myoblasts, and stable transfection of the ERMS cell line TE671, which does not express RAGE, with AGER results in reduced proliferation and formation of tumor masses in vivo, and enhanced apoptosis and myogenic differentiation. Herein, we show that RAGE expression is low or absent in human ERMSs. We also show that in ERMS cells (1) PAX7 accumulates owing to absent or low RAGE signaling; (2) elevated PAX7 levels reduce RAGE expression and levels of MyoD and myogenin, muscle-specific transcription factors required for myoblast proliferation arrest and differentiation, respectively; (3) PAX7 supports myoblast proliferation by reducing the levels of MyoD, primarily by promoting its degradation; and (4), when ectopically expressed in ERMS cells, that RAGE upregulates myogenin which upregulates MyoD and downregulates PAX7, with consequent inhibition of proliferation and stimulation of differentiation. Thus, failure to express RAGE and, hence, MyoD and myogenin above a critical level in ERMS cells might result in deregulated PAX7 expression leading to uncontrolled proliferation and, potentially, to rhabdomyosarcomagenesis.

Entities:  

Keywords:  Embryonal rhabdomyosarcoma; MyoD; Myogenin; PAX7; Proliferation; RAGE

Mesh:

Substances:

Year:  2014        PMID: 24554430     DOI: 10.1242/jcs.136259

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  10 in total

1.  In Vitro Model of Human Skeletal Muscle Tissue for the Study of Resident Macrophages and Stem Cells.

Authors:  Dandan Hao; Nils Becker; Eva Mückter; Aline Müller; Miguel Pishnamaz; Leo Cornelis Bollheimer; Frank Hildebrand; Mahtab Nourbakhsh
Journal:  Biology (Basel)       Date:  2022-06-19

2.  A Pilot Study Using a Multistaged Integrated Analysis of Gene Expression and Methylation to Evaluate Mechanisms for Evening Fatigue in Women Who Received Chemotherapy for Breast Cancer.

Authors:  Elena Flowers; Annesa Flentje; Jon Levine; Adam Olshen; Marilyn Hammer; Steven Paul; Yvette Conley; Christine Miaskowski; Kord M Kober
Journal:  Biol Res Nurs       Date:  2019-01-31       Impact factor: 2.522

Review 3.  Stem cell activation in skeletal muscle regeneration.

Authors:  Xin Fu; Huating Wang; Ping Hu
Journal:  Cell Mol Life Sci       Date:  2015-01-09       Impact factor: 9.261

4.  PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma.

Authors:  J A Hanna; M R Garcia; J C Go; D Finkelstein; K Kodali; V Pagala; X Wang; J Peng; M E Hatley
Journal:  Cell Death Dis       Date:  2016-06-09       Impact factor: 8.469

5.  Targeting myomiRs by tocotrienol-rich fraction to promote myoblast differentiation.

Authors:  Azraul Mumtazah Razak; Shy Cian Khor; Faizul Jaafar; Norwahidah Abdul Karim; Suzana Makpol
Journal:  Genes Nutr       Date:  2018-11-29       Impact factor: 5.523

Review 6.  Cellular and molecular mechanisms of sarcopenia: the S100B perspective.

Authors:  Francesca Riuzzi; Guglielmo Sorci; Cataldo Arcuri; Ileana Giambanco; Ilaria Bellezza; Alba Minelli; Rosario Donato
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-11-30       Impact factor: 12.910

7.  PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype.

Authors:  Shunlei Duan; Guohong Yuan; Xiaomeng Liu; Ruotong Ren; Jingyi Li; Weizhou Zhang; Jun Wu; Xiuling Xu; Lina Fu; Ying Li; Jiping Yang; Weiqi Zhang; Ruijun Bai; Fei Yi; Keiichiro Suzuki; Hua Gao; Concepcion Rodriguez Esteban; Chuanbao Zhang; Juan Carlos Izpisua Belmonte; Zhiguo Chen; Xiaomin Wang; Tao Jiang; Jing Qu; Fuchou Tang; Guang-Hui Liu
Journal:  Nat Commun       Date:  2015-12-03       Impact factor: 14.919

Review 8.  RAGE in the pathophysiology of skeletal muscle.

Authors:  Francesca Riuzzi; Guglielmo Sorci; Roberta Sagheddu; Sara Chiappalupi; Laura Salvadori; Rosario Donato
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-10-18       Impact factor: 12.910

9.  Myogenin is an essential regulator of adult myofibre growth and muscle stem cell homeostasis.

Authors:  Massimo Ganassi; Sara Badodi; Kees Wanders; Peter S Zammit; Simon M Hughes
Journal:  Elife       Date:  2020-10-01       Impact factor: 8.140

10.  Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia.

Authors:  Sara Chiappalupi; Guglielmo Sorci; Aleksandra Vukasinovic; Laura Salvadori; Roberta Sagheddu; Dario Coletti; Giorgia Renga; Luigina Romani; Rosario Donato; Francesca Riuzzi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-03-11       Impact factor: 12.910

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.